Bionano Genomics, Inc. (BNGO) stock
BNGONasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 12/3083% below fair value
$0.95+0.01 (+1.29%)
Close on Nov 17, 2026Market cap $11.21MP/E –Yield –
Bionano Genomics profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Bionano Genomics's profit margin for the twelve months ending Jun 30, 2026 was -106.6%. For fiscal 2025 it was -92.6%, against -364.0% the year before. The highest annual figure on record is -92.6% in fiscal 2025.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -92.6% | +271.4 |
| FY2024 | Dec 31, 2024 | -364.0% | +279.8 |
| FY2023 | Dec 31, 2023 | -643.7% | −166.8 |
| FY2022 | Dec 31, 2022 | -476.9% | −74.1 |
| FY2021 | Dec 31, 2021 | -402.8% | +80.6 |
| FY2020 | Dec 31, 2020 | -483.4% | −189.1 |
| FY2019 | Dec 31, 2019 | -294.3% | −140.2 |
| FY2018 | Dec 31, 2018 | -154.1% | +91.7 |
| FY2017 | Dec 31, 2017 | -245.8% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -90.8% | +11.0 |
| Q1 FY2026 | Mar 31, 2026 | -124.2% | −76.1 |
| Q4 FY2025 | Dec 31, 2025 | -99.8% | +146.8 |
| Q3 FY2025 | Sep 30, 2025 | -115.4% | +613.1 |
| Q2 FY2025 | Jun 30, 2025 | -101.8% | +106.9 |
| Q1 FY2025 | Mar 31, 2025 | -48.0% | +310.3 |
| Q4 FY2024 | Dec 31, 2024 | -246.5% | +162.9 |
| Q3 FY2024 | Sep 30, 2024 | -728.6% | +479.5 |
| Q2 FY2024 | Jun 30, 2024 | -208.8% | +240.5 |
| Q1 FY2024 | Mar 31, 2024 | -358.3% | +142.3 |
| Q4 FY2023 | Dec 31, 2023 | -409.4% | +61.4 |
| Q3 FY2023 | Sep 30, 2023 | -1208.0% | −767.5 |
| Q2 FY2023 | Jun 30, 2023 | -449.2% | +32.9 |
| Q1 FY2023 | Mar 31, 2023 | -500.7% | +25.2 |
| Q4 FY2022 | Dec 31, 2022 | -470.8% | −106.7 |
| Q3 FY2022 | Sep 30, 2022 | -440.5% | +5.3 |
| Q2 FY2022 | Jun 30, 2022 | -482.1% | +5.1 |
| Q1 FY2022 | Mar 31, 2022 | -525.8% | −211.9 |
| Q4 FY2021 | Dec 31, 2021 | -364.2% | −70.2 |
| Q3 FY2021 | Sep 30, 2021 | -445.8% | +45.6 |
| Q2 FY2021 | Jun 30, 2021 | -487.2% | +195.9 |
| Q1 FY2021 | Mar 31, 2021 | -314.0% | +611.2 |
| Q4 FY2020 | Dec 31, 2020 | -294.0% | −10.7 |
| Q3 FY2020 | Sep 30, 2020 | -491.4% | −298.3 |
| Q2 FY2020 | Jun 30, 2020 | -683.1% | −330.7 |
| Q1 FY2020 | Mar 31, 2020 | -925.2% | −501.4 |
| Q4 FY2019 | Dec 31, 2019 | -283.2% | −123.5 |
| Q3 FY2019 | Sep 30, 2019 | -193.1% | −19.0 |
| Q2 FY2019 | Jun 30, 2019 | -352.4% | −254.7 |
| Q1 FY2019 | Mar 31, 2019 | -423.7% | −206.2 |
| Q4 FY2018 | Dec 31, 2018 | -159.7% | −367.8 |
| Q3 FY2018 | Sep 30, 2018 | -174.1% | −359.5 |
| Q2 FY2018 | Jun 30, 2018 | -97.7% | −401.6 |
| Q1 FY2018 | Mar 31, 2018 | -217.6% | −548.0 |
| Q4 FY2017 | Dec 31, 2017 | 208.1% | – |
| Q3 FY2017 | Sep 30, 2017 | 185.4% | – |
| Q2 FY2017 | Jun 30, 2017 | 303.9% | – |
| Q1 FY2017 | Mar 31, 2017 | 330.4% | – |
See a number that looks wrong?